COMPOSITIONS FOR TREATMENT OF WET AGE-REALTED MACULAR DEGENERATION

Last updated:

Abstract:

A liquid suspension product comprising a recombinant adeno-associated virus (rAAV) having an AAV8 capsid which is suitable for intra-retinal injection is provided herein. Also provided herein are liquid suspensions containing these rAAV8.aVEGF and methods of using same for treatment of wet AMD and other ocular conditions.

Status:
Application
Type:

Utility

Filling date:

18 Feb 2019

Issue date:

1 Apr 2021